EDGAR·FLOW

Jaguar Health, Inc. — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
Jaguar Health approved and executed a reverse stock split at a 1-for-25 ratio (25 old shares → 1 new share), effective November 24, 2026 at 12:01 a.m. ET. The split was undertaken to maintain compliance with Nasdaq listing standards. Fractional shares are paid out in cash at the closing price on the effective date. No counterparties, dollar amounts, or financing terms are involved.
Why this rating

Reverse split is routine capital structure action, not a business event. Does not change market value, revenue, or operations—only share count. At $3.8M market cap, it is administrative, not material to company trajectory or investor economics.

View original filing on SEC.gov ↗ JAGX · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.